Lars Henningsohn
Papers
3
Total Citations
21
H-Index
3
About
Lars Henningsohn is a leading clinical researcher in urological oncology, with a focused expertise in postoperative rehabilitation for bladder cancer patients. His major contributions center on the critical period following robot-assisted radical cystectomy, where he has pioneered evidence-based exercise interventions to improve patient outcomes. Henningsohn’s work addresses the significant gap in physical rehabilitation after major abdominal surgery, demonstrating that structured exercise programs in primary care can reduce complications and hospital readmissions. His landmark CanMoRe trial, published in 2020, established the protocol for this innovative approach, while his subsequent 2024 randomized controlled trial provided compelling evidence of its efficacy. Complementing these quantitative findings, his qualitative study captured patients’ lived experiences with the intervention, offering invaluable insights into adherence and quality of life. With his most-cited papers accumulating over 20 citations, Henningsohn’s research is shaping a new standard of care for bladder cancer survivors. His work not only advances surgical recovery but also empowers patients to take an active role in their rehabilitation, bridging the gap between hospital-based care and long-term wellness in the community.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3